QT
RNAM

Quantamental Technologies’s Avidity Biosciences RNAM Stock Holding History

Quantamental Technologies’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,740
Closed -$305K – 588
2022
Q4 		$305K Buy
13,740
+610
+5% +$9.1K 0.14% 256
2022
Q3 		$214K Buy
+13,130
New +$251K 0.08% 402

Other funds holding RNAM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Quantamental Technologies's RNAM Position: Q1 2023 in Review

Quantamental Technologies sold out of Avidity Biosciences (RNAM) in Q1 2023, closing a stake of 13,740 shares — an estimated $305K sold.

Quantamental Technologies first reported a position in RNAM in Q3 2022 and held it in 2 quarters. The position peaked at $305K in Q4 2022. 139 funds tracked by Wall St. Rank hold RNAM as of Q1 2023.

  • Quantamental Technologies reported no remaining Avidity Biosciences position as of Q1 2023 after selling out during the quarter.
  • Quantamental Technologies sold 13,740 Avidity Biosciences shares in Q1 2023, an estimated $305K.
  • Quantamental Technologies first reported a position in Avidity Biosciences in Q3 2022 and held it in 2 quarters.
  • Quantamental Technologies's Avidity Biosciences position peaked at $305K in Q4 2022.
  • 139 funds tracked by Wall St. Rank held Avidity Biosciences as of Q1 2023.

Based on Quantamental Technologies's 13F filing for Q1 2023, filed 15 May 2023.